|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/3955 | (2013.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 47/50 | (2017.01) | ||
| A61P 37/06 | (2018.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2317/31 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61K 31/704 | (2013.01) | ||
| C07K 16/2809 | (2013.01) | ||
| A61K 31/454 | (2013.01) | ||
| A61K 39/39558 | (2013.01) | ||
| C07K 16/2878 | (2013.01) | ||
| A61P 43/00 | (2018.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61K 31/69 | (2013.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 47/6849 | (2017.08) | ||
| A61P 35/04 | (2018.01) | ||
| C07K2317/21 | (2013.01) | ||
| A61K 47/6801 | (2017.08) |
| (11) | Patento numeris | 3283106 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16714547.3 |
| Europos patento paraiškos padavimo data | 2016-03-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-02-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-12-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2016/051801 |
| Data | 2016-03-30 |
| (87) | Numeris | WO 2016/166629 |
| Data | 2016-10-20 |
| (30) | Numeris | Data | Šalis |
| 201562146843 P | 2015-04-13 | US | |
| 201562146504 P | 2015-04-13 | US | |
| 201662301582 P | 2016-02-29 | US |
| (72) |
KUO, Tracy Chia-Chien , US
CHAPARRO RIGGERS, Javier Fernando , US
CHEN, Wei , US
CHEN, Amy Shaw-Ru , US
PASCUA, Edward Derrick , US
VAN BLARCOM, Thomas John , US
BOUSTANY, Leila Marie , US
HO, Weihsien , US
YEUNG, Yik Andy , US
STROP, Pavel , US
RAJPAL, Arvind , US
|
| (73) |
Pfizer Inc. ,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | THERAPEUTIC ANTIBODIES AND THEIR USES |
| THERAPEUTIC ANTIBODIES AND THEIR USES |